Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' reply
Lancet Respir Med
.
2018 Feb;6(2):e7.
doi: 10.1016/S2213-2600(18)30021-3.
Authors
David A Lynch
1
,
Nicola Sverzellati
2
,
William D Travis
3
,
Thomas V Colby
4
,
Yoshikazu Inoue
5
,
Andrew G Nicholson
6
,
Suhail Raoof
7
,
Luca Richeldi
8
,
Christopher J Ryerson
9
,
Jay H Ryu
10
Affiliations
1
Department of Radiology, National Jewish Health, Denver, 80206 CO, USA. Electronic address:
[email protected]
.
2
Department of Medicine and Surgery, University of Parma, Parma, Italy.
3
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
4
Department of Pathology, Mayo Clinic Scottsdale, Scottsdale, AZ, USA.
5
Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
6
Department of Histopathology, Royal Brompton and Hospital NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, UK.
7
Division of Pulmonary Medicine, Lenox Hill Hospital, New York, NY, USA.
8
Unità Operativa Complessa di Pneumologia, Agostino Gemelli University Hospital of the Catholic University of the Sacred Heart, Rome, Italy.
9
Department of Medicine, University of British Columbia and St Paul's Hospital, Vancouver, BC, Canada.
10
Division of Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
PMID:
29413090
DOI:
10.1016/S2213-2600(18)30021-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Idiopathic Pulmonary Fibrosis*
Prognosis
Pulmonary Fibrosis*